Borneol alleviates oxidative stress via upregulation of Nrf2 and Bcl-2 in SH-SY5Y cells

Keyphrases

• Oxidative Stress 100%
• B-cell Lymphoma 2 (Bcl-2) 100%
• SH-SY5Y Cells 100%
• Borneol 100%
• Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) 100%
• Alzheimer's Disease 20%
• Apoptosis 20%
• Nuclear Translocation 20%
• Heme oxygenase-1 (HO-1) 20%
• Bcl-2-associated X Protein 20%
• Reactive Oxygen Species Production 20%
• Commercially Available 10%
• Neurodegenerative Diseases 10%
• Natural Compounds 10%
• Antioxidant System 10%
• Cell Viability 10%
• Decreased Expression 10%
• Therapeutic Agents 10%
• Fluorometer 10%
• Hopefulness 10%
• MTT Assay 10%
• Neuroprotective Effect 10%
• Neuroprotection 10%
• Cell Toxicity 10%
• Nrf2 Expression 10%
• 1-factor 10%
• Anti-apoptosis 10%
• Peptide Aggregation 10%
• Alzheimer's Disease Treatment 10%
• Neuroprotective Mechanisms 10%
• Intracellular Reactive Oxygen Species 10%
• Nuclear Factor-erythroid 2 p45-related Factor 2 10%
• Antioxidative Effect 10%
• Human Neuroblastoma Cells 10%
• Induced Toxicity 10%

Pharmacology, Toxicology and Pharmaceutical Science

• B Cell Lymphoma 100%
• Borneol 100%
• Transcription Factor Nrf2 100%
• Alzheimer's Disease 30%
• Reactive Oxygen Metabolite 20%
• Heme Oxygenase 1 20%
• Antioxidant 20%
• Neuroprotective Agent 20%
• Cytotoxicity 10%
• Antiapoptotic 10%
• Neuroprotection 10%
• Cell Viability 10%
• Neuroblastoma 10%
• Natural Product 10%
• Protein Bax 10%
• Prothrombin 10%
• Nuclear Factor 10%
• Combination Therapy 10%
• Degenerative Disease 10%
• Amyloid 10%